Skip to main content
Signal8

Elanco Animal Health Inc (ELAN)

Sector: Pharmaceutical Preparations

Industry: Drug Manufacturers - Specialty & Generic

Elanco Animal Health Incorporated logo

Elanco Animal Health Incorporated

NYSE:ELANHealthcare
+8.70%$25.74
CLOSED
AH$25.74+0.00%vs close
Mkt Cap$12.87B
Float494.41M
O/S499.83M
VOL11.51M sh
$ Vol$292.03M
RVOL2.11×
Inst Own-
SI6.3%
Dilution
Elanco Animal Health Incorporated logoNYSE:ELANClosed$25.74+8.70%
Historical Data
DateOpenHighLowCloseVolume
Nov 6, 202624.0726.2623.9725.7411,506,066
Nov 5, 202625.2425.2423.4323.686,712,169
Nov 4, 202625.1825.4524.6225.317,746,225
Nov 3, 202624.2324.8224.0724.576,460,441
Nov 2, 202623.5524.2323.3124.106,539,890
Oct 30, 202623.4823.4822.9323.063,453,607
Oct 29, 202622.8423.2522.7723.243,488,765
Oct 28, 202622.7522.9222.5622.654,394,101
Oct 27, 202622.9123.1922.5922.654,985,660
Oct 26, 202622.6223.0922.1822.964,205,515
Oct 23, 202622.4422.7622.3122.524,277,981
Oct 22, 202622.4322.8422.3522.694,452,452
Oct 21, 202622.9822.9822.2322.554,860,730
Oct 20, 202623.2923.4722.0322.708,247,153
Oct 19, 202623.7123.9623.4523.492,900,356
Oct 16, 202623.8724.1123.4123.555,166,172
Oct 15, 202622.8323.7922.8023.546,652,168
Oct 14, 202622.3822.9222.2622.554,942,920
Oct 13, 202622.6322.7722.2222.413,345,254
Oct 12, 202622.8822.9322.5522.564,652,949
Analyst Coverage
Analyst Coverage
ConsensusBuy
Price Target
Not available
Ratings Distribution
BUY
15
HOLD
4
SELL
2
TOTAL21
Insider Trades
InsiderTypeShares
Modi Rajeev A. profile photoModi Rajeev A.Grant/Award64.047
VanHimbergen Robert M profile photoVanHimbergen Robert MGrant/Award8.544
Simmons Jeffrey N profile photoSimmons Jeffrey NGrant/Award122.59
VanHimbergen Robert M profile photoVanHimbergen Robert MGrant/Award8.366
Simmons Jeffrey N profile photoSimmons Jeffrey NGrant/Award120.04
Modi Rajeev A. profile photoModi Rajeev A.Grant/Award62.715
Shareholders
-
Institutionalⓘ
(536)
1.0%
Insiderⓘ
(26)
1.9%
5%+ Owners
(1)
-
Unattributed (incl. retail)ⓘ
Insider1.0%
5%+ Beneficial1.9%
Sources: 13F, Form 4, 13D/13GO/S: 499.8M · as of 4 Nov 2026 · SEC cover page
Insiders & Institutional Holders
About

Elanco Animal Health, a firm dedicated to animal well-being, creates, produces, and commercializes a diverse array of solutions for both companion animals and livestock. For household pets, the company provides preventative health solutions, including parasiticides and vaccinations, designed to guard against common ailments like worms, fleas, and ticks, with notable brands such as Seresto, Advantage, Advantix, and Advocate.

Additionally, Elanco supplies therapeutic treatments for canine and feline conditions including pain, osteoarthritis, ear infections, cardiovascular issues, and dermatological problems, marketed under labels like Galliprant and Claro.

Its portfolio for agricultural animals encompasses vaccines, antibiotics, parasiticides, and other essential products for poultry and aquaculture farming. This segment also features nutritional supplements such as enzymes, probiotics, and prebiotics to support animal health and growth. Furthermore, the company offers a comprehensive suite of products for ruminant and swine operations, comprising vaccines, antibiotics, implants, and parasiticides, often recognized by brands like Rumensin and Baytril. Elanco distributes its offerings through various channels, including independent distributors, veterinary clinics, and a broad spectrum of farm animal producers, from cattle and dairy farms to pig, poultry, and aquaculture enterprises. Established in 1954, Elanco Animal Health Incorporated maintains its corporate headquarters in Greenfield, Indiana.

Key Metrics
Market Cap$12.87B
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership-

13F filers report 564.19M shares, more than the 499.83M outstanding, so no percentage is shown. 13F reports lag by a quarter and shares lent to short sellers can be counted twice.

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ExchangeNYSE
CountryUSUS
IPO DateSep 20, 2018
Shares Outstanding499.83M
Authorized Shares
Float494.41M
52-Week Range
$19.40$27.98
$25.74(74th percentile)
Volume
Average Daily Volume5.45M
11.51M today vs 5.45M avg(+111%)

30d Avg

5.45M

60d Avg

5.52M

90d Avg

5.40M

Earnings
Dividend History
No dividend history available
Compliance Status
Loading compliance data...